QUICK LINKS
July saw many companies report earnings with aggregate average sales and earnings growth of 4.6% and 11.0%, respectively, for all companies reporting globally. This was broadly in line with sales expectations and 6.2% ahead of third-party analyst forecasts of earnings. The earnings increase and positive surprises were most prevalent in the technology sector; however, share prices in the sector generally declined in part due to question marks over future level of growth and the sustainability of profit margins. Overall, the Bloomberg World Index gained 1.6%, while the Ashburton Global Equity Income Portfolio gained 3.5%.
Diversified Energy announced the acquisition of complementary, high-quality assets with low decline rates at an attractive price, which will be support future production growth. Their share price rose 24.5%.
Roche shares gained 17.2% following results from a phase 1 trial of an oral GLP-1 treatment demonstrated both safety and efficacy. It will however still be sometime before this pipeline product completes a pivotal study and potentially challenges the current injectables made by Novo Nordisk and Eli Lilly. The great raft of GLP-1 “me-too” pipeline products from the pharmaceutical industry suggests competition in this space ultimately being fierce. Such is the interest by investors in this space that there was only a muted reaction to the relatively large number of late-stage products discontinuing clinical trials. Results from the company at month end were 10% ahead of estimates and management raised guidance.
BAT reported results which pointed to an acceleration in second half performance with the launch of new categories and first half US investments gaining traction. The company also reaffirmed full year guidance and mentioned strong growth in reduced risk products, with the total number of vapour consumers accelerating. Shares gained 14.9%.
Merck (-8.6%) reported better-than-expected results in the second quarter, however cut its earning guidance to reflect its Eyebiotech and Harpoon Therapeutics acquisitions.
Microsoft’s results were in line with expectations, however the company announced plans to invest more in capital equipment to support more Cloud and Artificial Intelligence (AI) growth. Theirshares declined 6.4%.
Recent weaker-than-expected employment numbers sparked fears of a US recession as the Sahm Recession Indicator was triggered. The indicator signals the start of a recession when the three-month moving average of the US unemployment rate is at least 0.5% higher than the 12-month low. Although this indicator has historically been reliable, we do not believe the US will go into recession as the rise in unemployment figures was partly due to an increased participation ratio as more people move from ‘not working and not looking’ to ‘actively looking’ and employment growth was also positive. US Policymakers held interest rates at current levels in August; however, Federal Reserve Chair Jerome Powell signalled that September rate cuts were on the table. We, therefore, believe the global outlook for growth is positive and continue to look for opportunities especially in the broader market where certain sectors have not participated in higher markets year to date.
Disclaimer:
Waystone Management Company (Lux) S.A. is regulated by the Commission de Surveillance du Secteur Financier (CSSF) (ref A00000395 & S00000734), Waystone Management Company (Lux) S.A. is a company located in Luxembourg, L-1273 Luxembourg at 19, Rue de Bitbourg. This document is Issued by Ashburton Fund Managers (Pty) Limited (The Investment Manager) (Reg number 2002/013187/07), which has its registered office at 3 Merchant Place, 1 Fredman Drive, Sandton, 2196, South Africa and is an authorised financial services provider (FSP number 40169), registered with the Financial Sector Conduct Authority (FSCA). In South Africa, the Fund(s) is/are approved for promotion under section 65 of the Collective Investment Schemes Control Act 2002. The Fund Prospectus, and further information including pricing and changes, may be viewed at the Fund’s representative office in South Africa: Ashburton Management Company (RF) Proprietary Limited (“Ashburton CIS”), of the same address.
Ashburton CIS is an approved collective investment schemes manager regulated by the Financial Sector Conduct Authority and a full member of the Association of Saving and Investments South Africa. In the event a potential investor requires material risks disclosures for the foreign securities included in a portfolio, the manager will upon request provide such potential investor with a document, outlining potential constraints on liquidity & repatriation of funds; Macroeconomics risk; Political risk; Foreign Exchange risk; Tax risk; Settlement risk; and Potential limitations on the availability of market information. The value of participatory interests and the income from them may go down as well as up and is not guaranteed. Past performance is not necessarily a guide to the future performance. Where an investment involves exposure to a currency other than that in which it is denominated, changes in rates of exchange may cause the value of the investment to go up or down. CIS portfolios are traded at ruling prices and can engage in borrowing and scrip lending. A full detailed schedule of fees, charges and commissions is available from Ashburton on request and incentives may be paid and if so, would be included in the overall costs. The manager does not provide any guarantee either with respect to the capital or the return of a portfolio. The manager has a right to close the portfolio to new investors in order to manage the portfolio more efficiently in accordance with its mandate. This document does not constitute an offer or solicitation to any person in any jurisdiction in which Ashburton Fund Managers (Pty) Limited is not authorised or permitted to communicate with potential investors, or to anyone who would be an unlawful recipient. The original recipient is solely responsible for any actions in further distribution of this document and should be satisfied in doing so that there is no breach of local legislation or regulations. This is a marketing communication. Additional information about this product, including brochures, application forms and annual or half-yearly reports, can be obtained from the Manager, free of charge, and from the website: www.ashburtoninvestments.com.
The content or fund you have selected is not available for the profile or region you have selected. Please select one of the options below to return to the site.